Precision Spine and HippoFi inked an agreement to help drive the sales of Pur Biologics products.

Pensacola, Fla.-based Andrews Medicine, led by James Andrews, MD, is partnering with Houston-based Celltex Therapeutics to form a biotechnology company focused on stem cell research and sports medicine.

From executive leadership moves to new product developments, here are key headlines about orthopedic regenerative medicine from the third quarter: 

A two-year study found Creative Medical Technology's StemSpine procedure was effective for treating lower back pain, the biologics company said Sept. 26.

A randomized controlled trial found Smith+Nephew's Regeneten bioinductive implant is effective at preventing retearing after a rotator cuff repair.

Ventris Medical's Amplify synthetic bone graft putty earned FDA 510(k) clearance.

Ortho Regenerative Technologies is now called ChitogenX, the company said Sept. 7.

From CEO moves to product debuts, here are seven developments from regenerative medicine companies since July 22.

Aziyo Biologics named Michelle Williams, PhD, as chief scientist, the regenerative medicine company said Aug. 26.

Cesar Ceballos, MD, founder of OrthoMiami, performed Miami's first BEAR procedure — a case involving a 19-year-old patient.

Scripps Clinic in San Diego added the BEAR biologic implant for ACL restoration, CBS affiliate KFMB reported Aug. 23.

Richard Caruso, PhD, founder, former CEO and former chair of Integra lifeSciences, has died, the company said Aug. 16.

Randal "Randy" Mills, PhD, co-founder of Aziyo Biologics, assumed the role of president and CEO of the company.

Orthofix and CGBio partnered for the development and commercialization of Novosis, a bone growth material and regenerative products.

AlloSource's president and CEO, Tom Cycyota, plans to retire after leading the biologics company for 22 years.

Anika Therapeutics earned the American Orthopedic Society for Sports Medicine's ACE award for cutting-edge innovation for its Tactoset product.

Five orthopedic surgeons are part of a new regenerative medicine scientific advisory board for Mimedx.

Orthofix's Virtuos Lyograft allograft was debuted by neurosurgeon Thomas Ellis, MD.

NovaBone, a biologic medtech company focused on orthopedic and dental products, hired Brian Carlisle as CEO.

From a notable stem cell study to newly launched products, here are eight updates in regenerative orthopedic medicine: